Maravai Lifesciences Holdings (MRVI) Non-Current Deferred Tax Liability (2020 - 2025)
Maravai Lifesciences Holdings (MRVI) recorded quarterly Non-Current Deferred Tax Liability of $2.0 million in Q2 2025, up 2.74% quarter-over-quarter from $2.0 million in Q1 2025.
Maravai Lifesciences Holdings (MRVI) Non-Current Deferred Tax Liability (2020 - 2025) Analysis & Trends
Maravai Lifesciences Holdings' Non-Current Deferred Tax Liability history runs 5 years deep, the most recent figure standing at $2.0 million for Q2 2025.
- In Q2 2025, Non-Current Deferred Tax Liability changed N/A year-over-year to $2.0 million; the TTM figure through Jun 2025 stood at $2.0 million (changed N/A YoY), while the FY2024 annual figure was $11000.0, changed N/A from the prior year.
- Non-Current Deferred Tax Liability was $2.0 million for Q2 2025 at Maravai Lifesciences Holdings, up from $2.0 million in the prior quarter.
- In the past five years, Non-Current Deferred Tax Liability ranged from a high of $8.7 million in Q1 2023 to a low of $11000.0 in Q4 2024.
- Historically, Non-Current Deferred Tax Liability has averaged $5.2 million across 4 years, with a median of $6.7 million in 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Maravai Lifesciences Holdings | 747.50 Mn | 739.10 Mn | 33.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 2.03 Mn |
| Jun 30, 2025 | 2.03 Mn |
| Mar 31, 2025 | 1.97 Mn |
| Mar 31, 2025 | 1.97 Mn |
| Dec 31, 2024 | 11,000.00 |
| Dec 31, 2024 | 11,000.00 |
| Sep 30, 2023 | 6.69 Mn |
| Sep 30, 2023 | 6.69 Mn |
| Jun 30, 2023 | 8.51 Mn |
| Jun 30, 2023 | 8.51 Mn |
| Mar 31, 2023 | 8.68 Mn |
| Mar 31, 2023 | 8.68 Mn |
| Mar 31, 2021 | 8.57 Mn |
| Mar 31, 2021 | 8.57 Mn |
| Dec 31, 2020 | 8.61 Mn |
| Dec 31, 2020 | 8.61 Mn |